Allergy Bestselling Drug: Kyowa Yakuhin’s New North Pole Sinus Infection Capsule W
This article was originally published in PharmAsia News
Executive Summary
Kyowa Yakuhin's North Pole Sinus Infection Capsual W was identified as the top selling antihistamine drug, accounting for 60 percent of the oral allergy drug market, according to Shinjuku drug store chain Matsumoto Kyoshi. Second in sales was Sato Pharma's Sutonarini S. The convenience of taking the drug once or twice daily, coupled with long- lasting effects, are reasons for their popularity. However, side effect of drowsiness common in antihistamines turned some people to Kyorin Pharma's Cool One Sinus Infection Soft Capsule S, which has anti-drowsiness ingredients. OTC switches such as Daiichi Sankyo's AG series and Zaditen by Norvatis are also drawing attention. (Click for more-Japanese language
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.